Financials data is unavailable for this security.
View more
Year on year Epigral Ltd 's revenues fell -11.84% from 21.88bn to 19.29bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 3.53bn to 1.96bn, a -44.56% decrease.
| Gross margin | 40.51% |
|---|---|
| Net profit margin | 11.77% |
| Operating margin | 20.52% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Epigral Ltd fell by 110.57m. However, the company earned 3.98bn from its operations for a Cash Flow Margin of 20.61%. In addition the company used 4.01bn on investing activities and also paid 75.98m in financing cash flows.
| Cash flow per share | 90.59 |
|---|---|
| Price/Cash flow per share | 23.04 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -44.56%.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 8.30% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -9.67 |
More ▼
